On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy. [electronic resource]
Producer: 20180809Description: 341-346 p. digitalISSN:- 1728-7731
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.